Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma.

Loeb, David M

Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma. [electronic resource] - Cancer Dec 2010 - 5470-8 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

0008-543X

10.1002/cncr.25518 doi


Adolescent
Adult
Bone Neoplasms--radiotherapy
Female
Hematopoietic Stem Cell Transplantation--methods
Humans
Male
Organometallic Compounds--adverse effects
Organophosphorus Compounds--adverse effects
Osteosarcoma--radiotherapy
Radiometry
Radiopharmaceuticals--adverse effects
Transplantation, Autologous